首页> 外文期刊>The Internet Journal of Health >The Protective Role Of Ascorbic Acid Administration On The Bicalutamide Induced Reduction In Semen Quality In The Sprague - Dawley Rat.
【24h】

The Protective Role Of Ascorbic Acid Administration On The Bicalutamide Induced Reduction In Semen Quality In The Sprague - Dawley Rat.

机译:服用抗坏血酸对比卡鲁胺诱导的Sprague-Dawley大鼠精液质量降低的保护作用。

获取原文
           

摘要

Antineoplastic drugs used in the treatment of testicular carcinoma have been reported to have deleterious effects on the fertility potentials in affected males. The mechanism of damage involves the generation of free radicals.We evaluated the effect of using an antioxidant ascorbic acid as an adjuvant treatment with Bicalutamide on the androgen sensitive organs of the male Sprague-Dawley rats.Thirty-five adult male Sprague-Dawley rats weighing between 160-180 g were used for the experiment. The animals were randomly selected and divided into seven groups of five rats each. They were given 10 mg/kg or 20 mg/kg body weight of Bicalutamide and 200 mg/kg of Ascorbic acid for three and eight weeks. The animals were sacrificed and the cauda epididymides excised for sperm count and sperm motility analysis.There was observed decrease in semen quality with Bicalutamide that was attenuated by ascorbic acid co-administration. The concomitant administration of ascorbic acid has a protective role on reproductive function in males on Bicalutamide therapy. Introduction Bicalutamide is used for the treatment of prostatic and testicular cancers. These two forms of androgen specific cancers have an increasing incidence among the adult male populace (Potosky et al., 1995; Hans et al., 1996; Huvghe et al., 2003). Drugs used in chemotherapy of these malignancies adversely affects the reproductive function and may lead to infertility where there is still the desire to procreate (Robbins et al., 1998). Testicular cancer affects the reproductive age group with a peak age of incidence between 20 – 34 years (Huvghe et al., 2003). Though the incidence of prostatic carcinoma varies significantly across ethnic groups, peoples of African descent are at the highest risk (Alice et al., 1995; Parkin et al., 1999). The male reproductive organ malignancies are androgen sensitive having androgen receptors on their cellular membrane surfaces and therefore can be controlled or treated by the administration of anti androgens (Olea et al., 1990; Naohide et al., 1999).In Nigeria there is a burden of androgen sensitive tumours particularly that of the prostate. The incidence of prostatic carcinoma has been reported in literature to be on the increase (Ogunbiyi and Shittu, 1999; Ekwere and Egbe 2002). Some authors have reported that prostate cancer is the most commonly diagnosed cancer among male Nigerians (Ann and Susan, 2001). The incidence of testicular cancer on the other hand remains low in Nigeria (Magoha, 1995; Izegbu et al., 2005); the early age of onset however raises concern about future reproductive potentials of those affected (Stone et al., 2005).Infertility is an important medical problem of great social and cultural dimensions in Sub Saharan Africa, with several figures reported in literature for the Nigerian population (John and Pat, 1987; Robert et al., 1993).Anti-androgens either from the environment or iatrogenically administered are endocrine disruptors (Kelce and Wilson 1997; Jane, 2004) have deleterious effect on male reproductive function (Rex, 1998; Gray et al., 2001). Bicalutamide is an anti-androgen used in the chemotherapy of androgen sensitive tumours (Michael, 2002). The mode of action is by preventing testosterone from binding to the androgen receptors on the prostate and testicular cancer cells. It therefore starves the cancer cell of testosterone, which prevents their growth. Eventually the prostate and the testicular tumor will shrink (Amory, 2007). With the benefit of slowing down the tumor growth, it has also been implicated in the development of male infertility among those on treatment with the drug (Amory, 2007). Use of Antioxidants as agents to scavenge free radicals and reducing oxidative stress in reproductive organs is justifiable as increased oxidative stress has been shown to impair male reproductive function (Sikka et al., 1995; Sharma et al., 2001). The potential role of antioxidants, such as ascorbic acid, tocopherol, B-ca
机译:据报道,用于治疗睾丸癌的抗肿瘤药物对受影响男性的生育能力具有有害影响。损伤的机制涉及自由基的产生。我们评估了使用比卡鲁胺抗氧化剂抗坏血酸作为佐剂对雄性Sprague-Dawley大鼠雄激素敏感器官的影响。35只成年雄性Sprague-Dawley大鼠体重在160-180g之间用于实验。随机选择动物并分成七组,每组五只大鼠。在三,八周内给他们服用10毫克/千克或20毫克/千克体重的比卡鲁胺和200毫克/千克抗坏血酸。处死动物并切除附睾马尾毛进行精子计数和精子活力分析。观察到比卡鲁胺的精液质量下降,抗坏血酸联合给药减弱了精液质量。在比卡鲁胺治疗中,抗坏血酸的同时给药对男性生殖功能具有保护作用。简介比卡鲁胺用于治疗前列腺癌和睾丸癌。这两种形式的雄激素特异性癌症在成年男性民众中的发病率正在增加(Potosky等,1995; Hans等,1996; Huvghe等,2003)。在这些恶性肿瘤的化学疗法中使用的药物会对生殖功能产生不利影响,并可能导致不育,而在那里仍然有想要繁殖的希望(Robbins等,1998)。睾丸癌会影响生殖年龄组,发病高峰期在20-34岁之间(Huvghe等,2003)。尽管各族裔之间前列腺癌的发病率差异很大,但非洲人后裔的风险最高(Alice等,1995; Parkin等,1999)。男性生殖器官恶性肿瘤是雄激素敏感的,其细胞膜表面具有雄激素受体,因此可以通过施用抗雄激素来控制或治疗(Olea等,1990; Naohide等,1999)。在尼日利亚,雄激素敏感性肿瘤的负担,特别是前列腺的负担。文献报道前列腺癌的发病率正在增加(Ogunbiyi and Shittu,1999; Ekwere and Egbe 2002)。一些作者报告说,前列腺癌是男性尼日利亚人中最常被诊断出的癌症(Ann and Susan,2001)。另一方面,在尼日利亚,睾丸癌的发病率仍然很低(Magoha,1995; Izegbu等,2005)。然而,发病年龄的早期引起了人们对这些受感染者未来生殖潜能的担忧(Stone et al。,2005)。不育症是撒哈拉以南非洲具有重要社会和文化意义的重要医学问题,尼日利亚文献中报道了数个数字。 (John and Pat,1987; Robert et al。,1993)。来自环境或医源性施用的抗雄激素是内分泌干扰物(Kelce and Wilson 1997; Jane,2004)对男性生殖功能具有有害作用(Rex,1998)。 ; Gray等,2001)。比卡鲁胺是一种抗雄激素,用于雄激素敏感性肿瘤的化疗中(Michael,2002)。作用方式是通过防止睾丸激素与前列腺和睾丸癌细胞上的雄激素受体结合。因此,它会饿死睾丸激素的癌细胞,阻止其生长。最终,前列腺和睾丸肿瘤会缩小(Amory,2007)。由于减慢了肿瘤的生长,在使用药物治疗的人群中男性不育的发展也有牵连(Amory,2007)。使用抗氧化剂作为清除自由基和减少生殖器官氧化应激的药物是合理的,因为已证明增加的氧化应激会损害男性生殖功能(Sikka等,1995; Sharma等,2001)。抗氧化剂的潜在作用,例如抗坏血酸,生育酚,B-ca

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号